1. Home
  2. Analysis
  3. Gentamicin-sulfate
  4. Prograf

Gentamicin sulfate and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gentamicin sulfate and Prograf. Common interactions include rectal prolapse among females and nasopharyngitis among males.

The phase IV clinical study analyzes what interactions people who take Gentamicin sulfate and Prograf have. It is created by eHealthMe based on reports of 27 people who take Gentamicin sulfate and Prograf from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 06, 2022

27 people who take Gentamicin sulfate and Prograf together, and have interactions are studied.

What is Gentamicin sulfate?

Gentamicin sulfate has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 3,435 Gentamicin sulfate users for its effectiveness, alternative drugs and more.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 40,360 Prograf users for its effectiveness, alternative drugs and more.

Number of Gentamicin sulfate and Prograf reports submitted per year:

Gentamicin sulfate and Prograf drug interactions.

Common Gentamicin Sulfate and Prograf drug interactions by gender *:

female:

  1. Rectal prolapse
  2. Renal impairment
  3. Viral infection
  4. Abasia
  5. Blood pressure increased
  6. Conjunctivitis allergic
  7. Depression
  8. Diabetes mellitus
  9. Diarrhoea
  10. Encephalopathy

male:

  1. Nasopharyngitis
  2. Infection
  3. Injury
  4. Leiomyoma
  5. Neuropathy peripheral
  6. Osteoarthritis
  7. Ota's naevus
  8. Pharyngitis
  9. Plantar fasciitis
  10. Renal failure

Common Gentamicin Sulfate and Prograf drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. International normalised ratio increased
  2. Muscular weakness
  3. Nephrolithiasis
  4. Oedema
  5. Pneumonia
  6. Pruritus
  7. Pubis fracture
  8. Pyrexia
  9. Rectal prolapse
  10. Renal impairment

30-39:

  1. Depression
  2. Chronic kidney disease
  3. Renal failure
  4. Tubulointerstitial nephritis
  5. Hyperparathyroidism secondary
  6. Blood pressure increased
  7. Bone disorder
  8. Bronchitis
  9. Constipation
  10. Diabetes mellitus

40-49:

  1. Abdominal pain upper
  2. Calculus urinary
  3. Community acquired infection
  4. Gastroenteritis
  5. Glaucoma
  6. Headache
  7. Infected skin ulcer
  8. Infection
  9. Infection susceptibility increased
  10. Injury

50-59:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary
  3. Nephrogenic anaemia
  4. Renal failure
  5. Renal injury
  6. Weight decreased
  7. Alanine aminotransferase increased
  8. Blood beta-d-glucan increased
  9. C-reactive protein increased
  10. Fatigue

60+:

  1. Cytomegalovirus enterocolitis
  2. Interstitial lung disease
  3. Oedema
  4. Pneumonia
  5. Pyrexia
  6. Diffuse large b-cell lymphoma
  7. Encephalopathy
  8. Herpes zoster
  9. Pneumonia klebsiella
  10. Renal failure

Common conditions people have *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 22.22%
  2. Pain: 5 people, 18.52%
  3. Asthma: 4 people, 14.81%
  4. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 14.81%
  5. Hypersensitivity: 3 people, 11.11%
  6. Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 11.11%
  7. Sleep Disorder: 3 people, 11.11%
  8. Bacterial Infection: 3 people, 11.11%
  9. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 11.11%
  10. Erection Problems: 3 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin sulfate and Prograf?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Gentamicin sulfate and Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gentamicin sulfate side effects:

Browse all side effects of Gentamicin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prograf side effects:

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gentamicin sulfate interactions:

Browse all interactions between Gentamicin sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Prograf interactions:

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate and tacrolimus (the active ingredients of Gentamicin sulfate and Prograf, respectively), and Gentamicin sulfate and Prograf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gentamicin sulfate and Prograf.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.